Xiaoyang Li Selected Research

Synovial Sarcoma (Synovioma)

5/2022	Inhibition of CDK7-dependent transcriptional addiction is a potential therapeutic target in synovial sarcoma.
1/2019	Targeting regulation of cyclin dependent kinase 9 as a novel therapeutic strategy in synovial sarcoma.
1/2018	Inhibition of cyclin-dependent kinase 4 as a potential therapeutic strategy for treatment of synovial sarcoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoyang Li Research Topics

Disease

62	Neoplasms (Cancer) 04/2024 - 11/2012
13	Infections 01/2024 - 01/2016
11	Neoplasm Metastasis (Metastasis) 04/2024 - 11/2014
8	Inflammation (Inflammations) 04/2024 - 01/2020
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2024 - 01/2017
5	Sarcoma (Soft Tissue Sarcoma) 04/2024 - 09/2017
5	Osteosarcoma (Osteogenic Sarcoma) 12/2021 - 07/2016
5	Carcinogenesis 01/2019 - 06/2014
4	Hypertension (High Blood Pressure) 04/2024 - 01/2023
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023 - 02/2020
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 08/2023 - 06/2012
4	Hematologic Neoplasms (Hematological Malignancy) 08/2023 - 01/2017
4	Hypoxia (Hypoxemia) 01/2022 - 03/2017
3	Fibrosis (Cirrhosis) 04/2024 - 01/2022
3	Melanoma (Melanoma, Malignant) 04/2024 - 01/2022
3	Adenocarcinoma of Lung 01/2024 - 01/2021
3	Leukemia 01/2024 - 07/2017
3	Cognitive Dysfunction 01/2024 - 01/2023
3	Wounds and Injuries (Trauma) 01/2024 - 01/2022
3	Lymphoma (Lymphomas) 12/2023 - 06/2012
3	Pancreatic Neoplasms (Pancreatic Cancer) 10/2023 - 01/2022
3	Poisoning 01/2023 - 01/2020
3	Synovial Sarcoma (Synovioma) 05/2022 - 01/2018
2	Rectal Neoplasms (Rectal Cancer) 04/2024 - 01/2015
2	Ulcerative Colitis 02/2024 - 11/2023
2	Colitis 12/2023 - 01/2023
2	Multiple Myeloma 08/2023 - 01/2018
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 10/2020
2	Lung Neoplasms (Lung Cancer) 01/2023 - 01/2021
2	Breast Neoplasms (Breast Cancer) 01/2023 - 11/2022
2	Acute Promyelocytic Leukemia 12/2022 - 01/2016
2	Colorectal Neoplasms (Colorectal Cancer) 11/2022 - 07/2017
2	Mitochondrial Diseases (Mitochondrial Disease) 09/2022 - 01/2022
2	Stomach Neoplasms (Stomach Cancer) 01/2022 - 11/2014
2	Hyperplasia 10/2021 - 08/2019
2	Spinal Cord Injuries (Spinal Cord Injury) 10/2021 - 01/2020
2	Alzheimer Disease (Alzheimer's Disease) 10/2020 - 01/2020
2	Carcinoma (Carcinomatosis) 01/2020 - 01/2016
2	Necrosis 01/2020 - 01/2020
2	Demyelinating Diseases (Demyelinating Disease) 11/2019 - 11/2017
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 08/2018 - 09/2017
2	Liver Neoplasms (Liver Cancer) 01/2018 - 11/2016

Drug/Important Bio-Agent (IBA)

16	Histone Deacetylase InhibitorsIBA 01/2024 - 06/2014
12	Histone Deacetylases (Histone Deacetylase)IBA 12/2023 - 10/2014
11	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2017
5	Biomarkers (Surrogate Marker)IBA 04/2024 - 07/2016
5	InflammasomesIBA 03/2024 - 01/2021
5	ubenimexIBA 08/2023 - 01/2016
5	Fluorouracil (Carac)FDA LinkGeneric 11/2022 - 01/2016
4	LigandsIBA 04/2024 - 11/2018
4	VaccinesIBA 01/2024 - 01/2021
4	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2019
4	EnzymesIBA 01/2018 - 06/2014
3	Antiviral Agents (Antivirals)IBA 01/2024 - 01/2018
3	AntibodiesIBA 01/2024 - 11/2017
3	Tyrosine Kinase InhibitorsIBA 11/2023 - 01/2021
3	Chimeric Antigen ReceptorsIBA 08/2023 - 08/2018
3	ProdrugsIBA 01/2023 - 10/2016
3	MicroRNAs (MicroRNA)IBA 01/2023 - 09/2017
3	Therapeutic UsesIBA 01/2023 - 12/2016
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022 - 01/2017
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 06/2012
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2017
3	GoldIBA 05/2019 - 01/2016
2	Peptides (Polypeptides)IBA 04/2024 - 11/2022
2	PotassiumIBA 04/2024 - 09/2021
2	CytokinesIBA 03/2024 - 01/2023
2	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 10/2022
2	Decitabine FDA Link 12/2023 - 08/2019
2	ErbB Receptors (EGF Receptor)IBA 11/2023 - 11/2014
2	Lenalidomide (CC 5013)FDA Link 08/2023 - 03/2016
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2023 - 01/2023
2	Memantine (Namenda)FDA Link 01/2023 - 01/2023
2	CarbohydratesIBA 01/2023 - 01/2022
2	Bone Cements (Bone Glue)IBA 01/2023 - 07/2022
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2020
2	Adenosine Triphosphate (ATP)IBA 01/2023 - 12/2021
2	Gemcitabine FDA Link 01/2023 - 11/2016
2	CalciumIBA 09/2022 - 01/2022
2	RNA Polymerase II (RNA Polymerase B)IBA 05/2022 - 01/2022
2	Cytotoxins (Cytolysins)IBA 05/2022 - 01/2016
2	PanobinostatIBA 01/2022 - 06/2014
2	AntigensIBA 01/2022 - 10/2021
2	Messenger RNA (mRNA)IBA 12/2021 - 10/2021
2	NanovaccinesIBA 10/2021 - 01/2021
2	ApigeninIBA 01/2021 - 08/2019
2	ChromatinIBA 01/2020 - 01/2017
2	Histones (Histone)IBA 01/2020 - 01/2017
2	Vorinostat FDA Link 01/2018 - 05/2015
2	Capecitabine (Xeloda)FDA Link 01/2018 - 10/2016

Therapy/Procedure

30	Therapeutics 04/2024 - 06/2014
12	Drug Therapy (Chemotherapy) 02/2024 - 06/2012
7	Radiotherapy 04/2024 - 01/2021
7	Immunotherapy 01/2024 - 08/2018
4	Neoadjuvant Therapy 05/2024 - 01/2020
2	Cell- and Tissue-Based Therapy (Cell Therapy) 08/2023 - 08/2018
2	Precision Medicine 01/2022 - 12/2018
2	Oral Administration 01/2022 - 11/2016
2	Transplantation 01/2022 - 01/2016